Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening.
The interaction between beta-catenin and Tcf family members is crucial for the Wnt signal transduction pathway, which is commonly mutated in cancer. This interaction extends over a very large surface area (4800 A(2)), and inhibiting such interactions using low molecular weight inhibitors is a challe...
Autores principales: | Trosset, J, Dalvit, C, Knapp, S, Fasolini, M, Veronesi, M, Mantegani, S, Gianellini, L, Catana, C, Sundström, M, Stouten, P, Moll, J |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2006
|
Ejemplares similares
-
Hot spots in Tcf4 for the interaction with beta-catenin.
por: Fasolini, M, et al.
Publicado: (2003) -
NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligands.
por: Dalvit, C, et al.
Publicado: (2002) -
The Allosteric Site on SHP2’s Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules
por: Brennan Marsh-Armstrong, et al.
Publicado: (2018-11-01) -
Bioavailability Computations for Natural Phenolic Derivatives for Druglikeness Assessment
por: Amalia Stefaniu, et al.
Publicado: (2023-11-01) -
ADMET and Druglikeness Calculations of Sarin, Soman, and Their Hypothetical Derivatives
por: Kafa Khalaf Hammud
Publicado: (2022-12-01)